she experiences ongoing inflamed, intense joint and muscle pain; she experiences ongoing inflamed, intense joint and muscle pain; she experiences ongoing inflamed, intense joint and muscle pain; she experiences ongoing inflamed, intense joint and muscle pain; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRITIS (she experiences ongoing inflamed, intense joint and muscle pain), MYOSITIS (she experiences ongoing inflamed, intense joint and muscle pain), ARTHRALGIA (she experiences ongoing inflamed, intense joint and muscle pain) and MYALGIA (she experiences ongoing inflamed, intense joint and muscle pain) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 059H21A and 939905) for COVID-19 vaccination.     Concomitant products included ACETYLCYSTEINE (NAC [ACETYLCYSTEINE]), WITHANIA SOMNIFERA (ASHWAGANDHA [WITHANIA SOMNIFERA]), LYSINE, ZINGIBER OFFICINALE (GINGER [ZINGIBER OFFICINALE]), PROBIOTICS NOS, FISH OIL, CURCUMA LONGA (TURMERIC [CURCUMA LONGA]) and MULTIVITAMINS [VITAMINS NOS] for an unknown indication.   On 22-Nov-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Dec-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ARTHRITIS (she experiences ongoing inflamed, intense joint and muscle pain), MYOSITIS (she experiences ongoing inflamed, intense joint and muscle pain), ARTHRALGIA (she experiences ongoing inflamed, intense joint and muscle pain) and MYALGIA (she experiences ongoing inflamed, intense joint and muscle pain). At the time of the report, ARTHRITIS (she experiences ongoing inflamed, intense joint and muscle pain), MYOSITIS (she experiences ongoing inflamed, intense joint and muscle pain), ARTHRALGIA (she experiences ongoing inflamed, intense joint and muscle pain) and MYALGIA (she experiences ongoing inflamed, intense joint and muscle pain) had not resolved.            No allergies were reported. Patient had never ever had COVID positive test or diagnosis. No prior history relating to mentioned AE and both acute and chronic illnesses at the time of vaccination. No other vaccines given within 1 month prior to Moderna COVID-19 vaccine. Patient does not experienced similar event in the past. Patient states that flares throughout each day. Recent changes in status was reported as worse. Treatment included stretching and yoga. COMPANY COMMENT: This is an spontaneous case concerning a 42-years-old female patient with medical history of Concomitant products included ACETYLCYSTEINE, WITHANIA SOMNIFERA, LYSINE, ZINGIBER OFFICINALE, PROBIOTICS NOS, FISH OIL, CURCUMA LONGA and MULTIVITAMINS for an unknown indication who experienced the unexpected  events of ARTHRITIS (AESI), MYOSITIS and other expected events unknown days after  receiving 2nd  dose of  mRNA-1273 vaccine. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.; Sender's Comments: COMPANY COMMENT: This is an spontaneous case concerning a 42-years-old female patient with medical history of Concomitant products included ACETYLCYSTEINE, WITHANIA SOMNIFERA, LYSINE, ZINGIBER OFFICINALE, PROBIOTICS NOS, FISH OIL, CURCUMA LONGA and MULTIVITAMINS for an unknown indication who experienced the unexpected  events of ARTHRITIS (AESI), MYOSITIS and other expected events unknown days after  receiving 2nd  dose of  mRNA-1273 vaccine. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.